Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-18771906

RESUMO

BACKGROUND/AIM: Changes in tissue levels of 2-arachidonoylglycerol (2-AG), an endocannabinoid, during the evolution of bile duct ligation (BDL) may indicate that endocannabinoids have a role in the hemodynamic changes that occur in this condition. METHODS: 2-AG levels, in various organs and vascular beds of BDL rats, 2 and 4 weeks post surgery, were determined. Untouched and sham-operated (SO) rats were used as controls. RESULTS: 2-AG content of a specific organ was not a static finding and depended on the rat's age, the time from the surgical procedure and the type of procedure. The most pronounced changes were observed in BDL rats 4 weeks post surgery. In these rats, hepatic, pulmonary, cardiac and renal medullary and papillary 2-AG levels were highest observed. No changes in splenic, aortic and renal cortical 2-AG levels were observed. In addition a stepwise increase in 2-AG levels from the cortex to the papilla was detected and was followed by a decrease in creatinine clearance. CONCLUSIONS: 2-AG probably has a role in the pathophysiologic changes in the liver, heart, lung and kidney that follows BDL.


Assuntos
Ácidos Araquidônicos/metabolismo , Agonistas de Receptores de Canabinoides , Colestase Intra-Hepática/metabolismo , Glicerídeos/metabolismo , Animais , Artérias/metabolismo , Ductos Biliares/cirurgia , Encéfalo/metabolismo , Colestase Intra-Hepática/patologia , Modelos Animais de Doenças , Progressão da Doença , Endocanabinoides , Rim/metabolismo , Ligadura , Fígado/metabolismo , Pulmão/metabolismo , Miocárdio/metabolismo , Tamanho do Órgão , Especificidade de Órgãos , Ratos , Ratos Sprague-Dawley , Baço/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA